Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
24207 | 267 | 38.3 | 40% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
3631 | 865 | ST PETERSBURG BIOREGULAT GERONTOL//HISTORY OF CHROMATOGRAPHY//EPITHALON |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | AKR LYMPHOMA | Author keyword | 5 | 60% | 2% | 6 |
2 | APOPTOSIS RELATED GENE EXPRESSION | Author keyword | 2 | 67% | 1% | 2 |
3 | EUTHYMIC BALB C NU MICE | Author keyword | 1 | 100% | 1% | 2 |
4 | LONG LIVE ANIMALS | Author keyword | 1 | 100% | 1% | 2 |
5 | MALIGNANCY VARIANTS | Author keyword | 1 | 50% | 1% | 2 |
6 | ADV STAT METHODS | Address | 1 | 50% | 0% | 1 |
7 | AGE ADJUSTED THERAPY | Author keyword | 1 | 50% | 0% | 1 |
8 | AGE RELATED MALIGNANCY | Author keyword | 1 | 50% | 0% | 1 |
9 | CANCER AND AGING | Author keyword | 1 | 50% | 0% | 1 |
10 | COMMON MECHANISMS | Author keyword | 1 | 50% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AKR LYMPHOMA | 3 | 57% | 1% | 4 |
2 | MALIGNANCY VARIANTS | 3 | 100% | 1% | 3 |
3 | B 16 MELANOMA GROWTH | 2 | 67% | 1% | 2 |
4 | SUPRANORMAL TEMPERATURES | 1 | 50% | 1% | 2 |
5 | INCIDENCE TURNOVER | 1 | 33% | 1% | 2 |
6 | 2200 MICE | 1 | 29% | 1% | 2 |
7 | FEMALE CBA MICE | 0 | 33% | 0% | 1 |
8 | INITIATED CELLS | 0 | 33% | 0% | 1 |
9 | UNIQUE ASPECTS | 0 | 33% | 0% | 1 |
10 | BRDU | 0 | 10% | 1% | 3 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Designing ageing conditions in tumour microenvironment-A new possible modality for cancer treatment | 2009 | 5 | 65 | 28% |
Aging and cancer: Issues of basic and clinical science | 1997 | 79 | 91 | 13% |
Carcinogenesis and aging 20 years after: Escaping horizon | 2009 | 15 | 98 | 16% |
The relationship between aging and carcinogenesis: a critical appraisal | 2003 | 32 | 213 | 10% |
Cancer in rodents: Does it tell us about cancer in humans? | 2005 | 58 | 76 | 11% |
Aging biology and cancer | 2004 | 21 | 93 | 14% |
CANCER AND AGING | 1986 | 17 | 26 | 31% |
Genetic, epigenetic, dysgenetic and non-genetic mechanisms is tumorigenesis. II. Further delineation of the rate limiting step | 1999 | 7 | 64 | 16% |
Metastatic melanoma in the older patient: immunologic insights and treatment outcomes | 2011 | 1 | 33 | 9% |
Cancer and aging: symposium of the 27th annual meeting of the Japanese society for biomedical gerontology, Tokyo | 2005 | 6 | 108 | 15% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ADV STAT METHODS | 1 | 50% | 0.4% | 1 |
2 | CARCINOGENESIS AGING | 1 | 19% | 1.1% | 3 |
3 | RI MUHC | 0 | 18% | 0.7% | 2 |
4 | AGING DEV SCI | 0 | 100% | 0.4% | 1 |
5 | CARCINORGENESIS ONCOGERONTOL | 0 | 100% | 0.4% | 1 |
6 | EARTH MAGNETISM IONOSPHERE | 0 | 100% | 0.4% | 1 |
7 | ST PETERSBURG AFFILIATED | 0 | 100% | 0.4% | 1 |
8 | UNITE RADIOBIOCHEM | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000203615 | ACUTE MORBILLI INFECTION//// |
2 | 0.0000169751 | ST PETERSBURG BIOREGULAT GERONTOL//EPITHALON//NORTHWESTERN |
3 | 0.0000120030 | MICROPROTEIN ASSAY//BIOLOGICAL MONITORING GUIDANCE VALUES//HUMAN CELLS IN VITRO |
4 | 0.0000097297 | MVK MODEL//CLONAL GROWTH MODEL//TSCE MODEL |
5 | 0.0000095619 | PROGRESSIVE STATE SELECTION//SPONTANEOUS TRANSFORMATION//GROWTH CONSTRAINT |
6 | 0.0000089043 | INVASION & METASTASIS//CLINICAL & EXPERIMENTAL METASTASIS//ND2001 |
7 | 0.0000080435 | 5 BROMODEOXYURIDINE//AT TRACT//EXCESS THYMIDINE |
8 | 0.0000078975 | HYG PUBL HLTH MED//MESOGENESIS//TOKYO HLTH ADM |
9 | 0.0000077361 | BOWMAN GRAY MED MICROBIOL IMMUNOL//C 14 LEUCINE INCORPORATION//SOCIAL SCI STAT |
10 | 0.0000073116 | ADV AGING BRAIN//DNA GAP REPAIR//DNA DAMAGE SUSCEPTIBILITY |